Learning objectives: Describe the impact of immunotherapies in treating relapsed/refractory diffuse large B cell lymphoma.

Discuss how immunotherapy response may be influenced by unique immune landscapes that exist among diffuse large B cell lymphomas.

Session date: 
05/30/2023 - 12:00pm to 1:00pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Justin Kline, MD